Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-14 07:50 am Sale |
2024-12-31 | 13G | Disc Medicine, Inc. IRON |
Bain Capital Life Sciences Opportunities III, LP | 983,500 3.300% |
-812,235 (-45.23%) |
Filing History |
| 2024-11-14 5:44 pm Purchase |
2024-09-30 | 13G | Disc Medicine, Inc. IRON |
Bain Capital Life Sciences Opportunities III, LP | 1,795,735 6.000% |
463,190 (+34.76%) |
Filing History |
| 2024-08-22 6:10 pm Purchase |
2024-08-12 | 13G | Cabaletta Bio, Inc. CABA |
Bain Capital Life Sciences Opportunities III, LP | 2,760,888 5.700% |
760,888 (+38.04%) |
Filing History |
| 2024-04-25 4:48 pm Purchase |
2024-04-15 | 13G | Century Therapeutics, Inc. IPSC |
Bain Capital Life Sciences Opportunities III, LP | 5,320,331 6.600% |
5,320,331 (New Position) |
Filing History |
| 2024-02-14 5:20 pm Purchase |
2024-02-07 | 13G | Kyverna Therapeutics, Inc. KYTX |
Bain Capital Life Sciences Opportunities III, LP | 3,163,868 7.400% |
3,163,868 (New Position) |
Filing History |
| 2024-02-13 6:51 pm Sale |
2023-12-31 | 13G | Disc Medicine, Inc. IRON |
Bain Capital Life Sciences Opportunities III, LP | 1,332,545 5.500% |
-658,369 (-33.07%) |
Filing History |
| 2024-02-13 6:50 pm Sale |
2023-12-31 | 13G | Cara Therapeutics, Inc. CARA |
Bain Capital Life Sciences Opportunities III, LP | 0 0.000% |
-224,669 (Position Closed) |
Filing History |
| 2024-02-13 6:47 pm Unchanged |
2023-12-31 | 13G | Cabaletta Bio, Inc. CABA |
Bain Capital Life Sciences Opportunities III, LP | 2,000,000 4.700% |
0 (Unchanged) |
Filing History |
| 2023-06-01 4:45 pm Purchase |
2023-05-22 | 13G | Cabaletta Bio, Inc. CABA |
Bain Capital Life Sciences Opportunities III, LP | 2,000,000 5.000% |
2,000,000 (New Position) |
Filing History |
| 2023-02-24 4:45 pm Purchase |
2023-02-15 | 13G | Disc Medicine, Inc. IRON |
Bain Capital Life Sciences Opportunities III, LP | 1,990,914 9.990% |
1,990,914 (New Position) |
Filing History |
| 2022-11-18 4:16 pm Purchase |
2022-11-09 | 13G | Cara Therapeutics, Inc. CARA |
Bain Capital Life Sciences Opportunities III, LP | 224,669 5.000% |
224,669 (New Position) |
Filing History |